A year like no other requires a new way of drafting a list of Best Biopharma CEOs.
For 2020 — the 13th iteration of this list — Covid needed its own category. The worst public health crisis of our lives has triggered an unprecedented response from biotech and pharma companies developing vaccines and drugs against the novel coronavirus. This effort has dominated everything else.
About the Author Reprints
